omeprazole has been researched along with glucagon in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, N; Fukuda, H; Funakoshi, A; Funakoshi, S; Kitani, K; Miyasaka, K; Nakamura, J | 1 |
| Tarui, S | 1 |
| Allen, JM; Bishop, AE; Bloom, SR; Carlsson, E; Daly, MJ; Larsson, H; Polak, JM | 1 |
| Becker, HD | 1 |
| Bahekar, R; Detroja, J; Dhanesha, N; Dhote, V; Gandhi, T; Jain, M; Joharapurkar, A; Kshirsagar, S; Patel, K; Patel, V | 1 |
1 review(s) available for omeprazole and glucagon
| Article | Year |
|---|---|
[Zollinger-Ellison syndrome].
Topics: Benzimidazoles; Calcium; Cimetidine; Diarrhea; Duodenal Ulcer; Female; Fluorouracil; Gastrectomy; Gastric Acid; Gastrins; Glucagon; Humans; Male; Middle Aged; Omeprazole; Pancreatic Neoplasms; Prognosis; Ranitidine; Secretin; Streptozocin; Zollinger-Ellison Syndrome | 1984 |
4 other study(ies) available for omeprazole and glucagon
| Article | Year |
|---|---|
Stimulatory effects of islet amyloid polypeptide (amylin) on exocrine pancreas and gastrin release in conscious rats.
Topics: Amyloid; Animals; Atropine; Blood Glucose; Gastrins; Glucagon; Insulin; Islet Amyloid Polypeptide; Islets of Langerhans; Kinetics; Male; Omeprazole; Pancreas; Rats; Rats, Inbred Strains | 1992 |
[Progress of gastrin research--from gene to big gastrin N-terminal fragment].
Topics: Amino Acid Sequence; Chromatography; Gastric Mucosa; Gastrins; Glicentin; Glucagon; Glucagon-Like Peptides; Histamine; Humans; Molecular Sequence Data; Omeprazole; Peptide Fragments; Protein Conformation; Protein Precursors; Stomach Ulcer | 1990 |
Effect of inhibition of acid secretion on the regulatory peptides in the rat stomach.
Topics: Animals; Benzimidazoles; Gastric Acid; Gastric Fundus; Gastric Mucosa; Gastrins; Glucagon; Omeprazole; Peptides; Pyloric Antrum; Rats; Somatostatin; Stomach | 1986 |
Omeprazole improves the anti-obesity and antidiabetic effects of exendin-4 in db/db mice (-4 db/db)*.
Topics: Animals; Anti-Obesity Agents; Body Weight; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Exenatide; Gastrins; Glucagon; Hypoglycemic Agents; Insulin Resistance; Leptin; Male; Mice; Mice, Inbred Strains; Mice, Obese; Obesity; Omeprazole; Peptides; Venoms | 2013 |